This patient is not a candidate for systemic therapy and declines surgical treatment. Which of the following injectable agents is an oncolytic virus that is FDA-approved for inoperable disease?
A) Talimogene laherparepvec (T-VEC)
B) Interleukin-2
C) GM-CSF
D) Rose bengal
E) bacille Calmette-Guerin (BCG)
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review
